Basit öğe kaydını göster

dc.contributor.authorÇETİN, İHSAN
dc.contributor.authorDemirel, Omer F.
dc.date.accessioned2021-03-05T11:14:07Z
dc.date.available2021-03-05T11:14:07Z
dc.date.issued2018
dc.identifier.citationÇETİN İ., Demirel O. F. , "Increased serum levels of spectrin degradation products in patients with schizophrenia", TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.43, ss.22-29, 2018
dc.identifier.issn0250-4685
dc.identifier.otherav_a7292c90-a1d8-4cf2-be4f-b1fd5a6b83a9
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/111756
dc.identifier.urihttps://doi.org/10.1515/tjb-2017-0142
dc.description.abstractObjective: Under various patho-physiological and physiological conditions, spectrin breakdown reactions generate several spectrin breakdown products of 120 kDa (SBDP120) and 145 kDa (SBDP145). Previous studies indicating that there is the existence of a raised breakdown of alpha-spectrin in schizophrenic left superior temporal cortices. In this study, we aimed to investigate serum levels of SBDP120 and SBDP145, which has not been previously examined, and investigate their relationships with clinical parameters in patients with schizophrenia.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectSitogenetik
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.titleIncreased serum levels of spectrin degradation products in patients with schizophrenia
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
dc.contributor.departmentHitit Üniversitesi , Tıp Fakültesi , Tıbbi Biyokimya Anabilim Dalı
dc.identifier.volume43
dc.identifier.issue1
dc.identifier.startpage22
dc.identifier.endpage29
dc.contributor.firstauthorID251224


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster